Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account
 
  • BioCardia-Final-Logo-2016-JPEG.jpg
    December 22, 2022 07:00 ET | Source: BioCardia, Inc.
    BioCardia Letter to Shareholders

    SUNNYVALE, Calif., Dec. 22, 2022 (GLOBE NEWSWIRE) -- BioCardia, Inc. (Nasdaq: BCDA), a clinical-stage developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and...